|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 静脉血栓栓塞显示文摘静脉血栓栓塞,包括深静脉血栓形成与肺动脉栓塞,普通可见,在医院和院外均可进行治疗主要危险因素包括年龄、近期手术(特别是整形手术)、癌症及血栓形成倾向已确立的治疗有普通肝素、低分子量肝素。 | Andrew D Blann Gregory Y H Lip 刘仁斌(译) 王深明(校) | 2006 | 英国医学杂志中文版2006，9，5： | 6 |
| 2 | Endothelial Dysfunction and Damage in Congestive Heart Failure: Relation of Flow-Mediated Dilation to Circulating Endothelial Cells, Plasma Indexes of Endothelial Damage, and Brain Natriuretic Peptide显示文摘 | Aun Yeong Chong Andrew D. Blann Jeetesh Patel Bethan Freestone Elizabeth Hughes Gregory Y.H. Lip | 2004 | Circulation2004，，13： | 2 |
| 3 | Relationship of homocysteine to markers of platelet and endothelial activation in ‘high risk’ hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial显示文摘 | Charles G.C. Spencer Steven C. Martin Dirk C. Felmeden Andrew D. Blann Gareth D. Beevers Gregory Y.H. Lip | 2004 | International Journal of Cardiology2004，，2： | 2 |
| 4 | Is soluble P-selectin a new marker of platelet activation显示文摘 | Blann AD Lip GYH | 1997 | Atherosclerosis1997，128，： | 2 |
| 5 | Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers 显示文摘 | Blann AD Lip GY Beevers DG | 1997 | Thromb Haemost1997，77，6： | 1 |
| 6 | Soluble P-selection in atherosclerosis:A comparison with endotheial cell and piatelet markers显示文摘 | Lop GYH Beevers DG | 1997 | Thromb Heamost1997，，： | 1 |
| 7 | Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report显示文摘 | Lip GY Blann AD Zarifis J | 1995 | J Hypertens1995，13，： | 1 |
| 8 | Ciculating van Willebrand factor antigen Ⅱ in atherosclerosis:a comparison with yon Willebrand factor and soluble thrombomodulin显示文摘 | Blann AD de Romeuf C Mazurier C | 1998 | Blood Coagul Fibrinolysis1998，9，3： | 1 |
| 9 | Circulating endothelial cell markers in peripheral vascular disease, relationship to the location and extent of atherosclerotic disease显示文摘 | Blann AD Seigneur M Steiner M | 1997 | Eur J Clin Invest1997，27，： | 1 |
| 10 | Von Willebrand Factor,Soluble P-selectin,and Target Organ Damage in Hypertension:A Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)显示文摘 | Spencer C G Gurney D Blann A D | 2002 | Hypertension2002，40，： | 1 |
| 11 | A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation显示文摘 | Blann AD Chin BS | 2002 | J Am Coll Cardiol2002，40，： | 1 |
| 12 | Effects of acute exercise on hemorheological,endothelial,and platelet markers in patients with chronic heart failure in sinus rhythm显示文摘 | Gibbs CR Blann AD Edmunds E | 2001 | Clin Cardio12001，24，11： | 1 |
| 13 | Abnormali- ties of hemorhelogical, endothelial, and platelet func- tion in patients with chronic heart failure in sinus rhythm: effects of angiotensin - converting enzyme in- hibitor and beta - blocker therapy 显示文摘 | Gibbs CR Blann AD Watson RD | 2001 | Circulation2001，103，13： | 1 |
| 14 | Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dys-function in systemic lupus erythematosus 显示文摘 | Constans J Dupuy R Blann A D | 2003 | J Rheumatol2003，30，9： | 1 |
| 15 | Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells显示文摘 | Makin AJ Blann AD Chung NAY | 2004 | European Heart J2004，25，： | 1 |
| 16 | Plasma VEGF and soluble VEGF receptor FLT - 1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment 显示文摘 | Lip PL Belgore F Blann AD | 2000 | Invest Ophthalmol Vis Sci2000，41，8： | 1 |
| 17 | Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy显示文摘 | Gibbs CR Blann AD Watson RD | 2001 | Circulation2001，103，13： | 1 |
| 18 | A contemporary view on endothelial function in heart failure显示文摘 | Shantsila E Wrigley BJ Blann AD | 2012 | Eur J Heart Fail2012，14，8： | 1 |
| 19 | Von willebrand factor, soluble P-selectin, and target organ damage in hypertension:A sub-study of the angloscandinavian cardiac outcomes trial (ASCOT) 显示文摘 | Spencer CG Gurney D Blann AD | 2002 | Hypertension2002，40，1： | 1 |
| 20 | Hypothesis: is soluble P-selectin a new marker of platelet activation? 显示文摘 | Blann AD Lip GY | 1997 | Atherosclerosis1997，128，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员